Real Patch or Sticker? How to Tell If a Peptide Patch Can Actually Deliver Anything

Search “peptide patch” on Reddit and the reaction is often blunt. Plenty of commenters call these products scams, and a common standard is that a patch isn't credible unless the company can explain how the ingredient gets through the skin. [1][2] Honestly, for many products that skepticism is earned.

This guide covers why many patches struggle, the four real ways a product can get past the skin barrier, and seven questions that separate a delivery system from a sticker. It also covers what LavION has and hasn't established, because the same questions apply to us.

Why people are skeptical, and why they're often right

The patch aisle has a credibility problem. Products sold as “GLP-1 patches” are a clear example. In one case reported by PBS NewsHour and the Associated Press, a brand marketed its patch as increasing the body's own production of GLP-1, rather than containing a GLP-1 medication, and the experts interviewed noted that some products don't clearly list their ingredients at all. [3] Reddit discussions of these products are overwhelmingly skeptical. [4]

NAD+ and BPC-157 patches get similar treatment, with commenters asking a simple question: how does the ingredient actually get through the skin? [1][2] That's a fair standard, and it's the one this guide uses.

The skin barrier and the 500 Dalton rule

The outer layer of skin, the stratum corneum, is a tightly packed layer of dead cells and fats. It keeps water in and most things out.

In 2000, dermatologists Jan Bos and Marcus Meinardi pointed out that common contact allergens, topical dermatology drugs and the drugs used in transdermal patches all have molecular weights under about 500 daltons (Da), and they proposed 500 Da as a practical upper limit for passive skin penetration. [5] It's a rule of thumb rather than a law. For passive diffusion, how fat-soluble a molecule is and how it interacts with water also matter.

Here's how common wellness ingredients compare:

* Molecular weights from PubChem and UniProt. [6][7] Net charges are approximate values calculated from each molecule's structure at the pH of body tissue. The skin surface is more acidic, and a formulation's pH can change a molecule's charge. “TB-500” doesn't always mean the same molecule. In anti-doping research it refers to a synthetic version of a short active region of thymosin β4 (Ac-LKKTETQ, about 889 Da) [8], while many products use the name for the full-length peptide. The TB-500 in LavION formulas is full-length thymosin β4, confirmed by mass spectrometry on its certificate of analysis. If you're comparing products, ask which one you're getting.

Most of these molecules are above the 500-dalton line, and nearly all of them are water-loving and electrically charged. For a patch that relies on simple contact, that's a hard combination.

Molecular weight isn't the only factor, though, and it matters less once an electric current is involved. In iontophoresis, a molecule's charge, its charge relative to its size, the formulation's pH, competing ions in the formula and the current density all affect transport, and the current-driven flow of water through the skin can carry neutral and larger molecules along. [9] The 500 Dalton rule describes passive diffusion well. It doesn't, on its own, predict what iontophoresis can move.

Four terms that get confused: load, transport, bioavailability and effect

Patch marketing often blurs four different things. Keeping them separate is the fastest way to judge a claim.

A label number is a load. If a brand jumps from the load to promises about effects without data for the steps in between, or calls its load a “delivered dose,” it's skipping steps.

The four ways past the barrier

Every transdermal product falls into one of these categories, or combines them. A trustworthy brand will tell you which one it uses.

1. Passive diffusion. The ingredient sits on the skin and moves only along a concentration gradient. This works for small, fat-soluble drugs, which is why nicotine and some hormone patches exist. [10] It works poorly for large, charged, water-loving molecules like most peptides.

2. Chemical permeation enhancers. Solvents, surfactants and other chemicals (DMSO is the one Reddit mentions most) can increase permeability by disrupting the skin's lipid structure or changing how an ingredient moves into the skin. [11] They help some molecules, but their effect on large, water-loving molecules is generally limited, and the concentrations that work best tend to irritate skin. [10][11]

3. Microneedles. Arrays of microscopic projections create temporary channels through the outer layer of skin. Research shows they can deliver a range of molecules, including peptides and vaccines. [12][10] They still physically penetrate the skin, and “microneedle” is sometimes used loosely in marketing, so ask what the projections are made of and how long they are.

4. Iontophoresis. A low electric current between two electrodes adds a driving force to move molecules into the skin. It works in two ways: [9]

• Electromigration: charged molecules move in the electric field. A positively charged molecule is pushed away from the positive electrode, and a negatively charged one away from the negative electrode.
• Electroosmosis: the current also creates a gentle flow of water through the skin. Because skin carries a net negative charge at physiological pH, that flow runs from the positive electrode toward the negative one, which favors delivery of positively charged and neutral molecules from the positive side.

Iontophoresis isn't new. It has been used clinically for decades, including in sweat testing with pilocarpine, and the FDA has approved iontophoretic systems for delivering drugs such as lidocaine and fentanyl. [9][10]

What the research shows, and what it doesn't. Laboratory and clinical studies show that iontophoresis can increase skin transport of some peptides and larger molecules compared with passive diffusion. Results depend heavily on the molecule's charge and size, the formulation, pH and the current. [9][13][14] That's evidence about the method in general. It isn't evidence that any particular product, including LavION, delivers a specific amount of a specific peptide.

Seven questions that separate a patch from a sticker

Use these on any brand, including us. Our answers are in the next section.

1. What moves the ingredient through the skin? A credible answer names a mechanism (passive diffusion, chemical enhancer, microneedles or iontophoresis) and explains it in plain words. “Advanced transdermal technology” or “nano delivery” isn't an answer.

2. Does the product actually contain the ingredient on the box? Watch for “supports,” “boosts” or “promotes natural production of.” That wording often means the named ingredient isn't in the product at all.

3. How many milligrams of each ingredient are in each patch? The label should list milligrams for each active ingredient. “Proprietary blend” or “complex” isn't a dose.

4. Is that number the load, or a claim about absorption? Honest brands call it the loaded amount. If a brand claims an absorption or bioavailability percentage, ask for the published study, and check that it tested that product in people.

5. How long is it worn, and why? A 30-minute cosmetic patch and a 12-hour wearable are different products. For iontophoresis, also ask about the electrical dose, meaning the current multiplied by the time, since transport of charged molecules scales with the total charge passed. [9]

6. Is each batch third-party tested, and can I see the certificate of analysis? Independent identity and purity testing is the minimum for any product containing peptides.

7. What does the company say it hasn't established? This is the most telling question. A company that's clear about what it hasn't measured is usually more trustworthy than one that claims to have it all figured out.

Red flags

• An absorption or “bioavailability” percentage with no published human study of that product
• Claims that a patch is “just as effective as” an injection or IV
• Weight-loss or GLP-1 claims for a product that contains no GLP-1 medication
• Instant-results promises, such as “feel it in 20 minutes”
• No ingredient amounts, or vague “complexes” and “blends”
• Disease-treatment claims for a wellness product
• No real company behind it: no address, no way to reach a person, no lot numbers, no clinician or medical advisor you can look up
• The same photos, copy and price as another brand's listing

Not a sticker. A device: where LavION fits

LavION is a wearable iontophoresis patch. Each one has a built-in power source and two electrodes and runs at a very low current, averaging about 0.1 mA, for up to 12 hours. Over a full wear window, that adds up to a defined electrical dose of 80 mA-min (milliamp-minutes, or current multiplied by time). The current is low enough that most people feel little or nothing.

That's what we mean by “not a sticker. A device.” The patch applies a defined electrical driving force instead of relying on contact alone. It's a statement about the delivery mechanism, not a claim about how much of any ingredient is absorbed.

Here's how LavION answers the seven questions:

What LavION has and hasn't established

• Established in general science: iontophoresis is a recognized method of electrically assisted transport through the skin and has been used clinically for decades. [9][10]
• Known about the LavION device and formulas: each patch delivers a defined electrical dose, each formula contains a documented load of each ingredient, and each batch has a certificate of analysis.
• Not yet established for LavION: how much of each ingredient is transported into the skin, how much reaches the bloodstream, how LavION compares with an injection or IV, and what clinical outcomes LavION use produces. LavION doesn't have published human pharmacokinetic data, and it doesn't have published head-to-head human data showing equivalence to an injection. We don't claim it does.
• Evidence varies by ingredient: this refers to published research on the ingredients themselves, not studies of LavION. NAD+, glutathione and GHK-Cu have human research, with the extent varying by outcome. Much of the human outcome data for NAD+ comes from oral precursors, and the strongest human data for GHK-Cu is in topical skin studies. BPC-157, TB-500, MOTS-c and KPV are supported mainly by animal and laboratory studies.

If you currently inject, we're not asking you to stop. LavION is a needle-free option for the days, trips or clients where an injection isn't the right fit. For a full comparison, read Transdermal vs Injectable Peptides.

References

1. 1.Reddit, r/tirzepatidecompound. “Thoughts on NAD patches.” Consumer discussion, cited only to show consumer questions and skepticism, not as a scientific source. reddit.com
2. 2.Reddit, r/bpc_157. “Anyone who has experiences with BPC-157 patches?” Consumer discussion, cited only to show consumer questions and skepticism, not as a scientific source. reddit.com
3. 3.PBS NewsHour (Associated Press). What to know before you buy a weight-loss supplement on TikTok. July 28, 2025. News reporting on consumer marketing. pbs.org
4. 4.Reddit, r/glp1. “Are patches a fraud?” Consumer discussion, cited only to show consumer questions and skepticism, not as a scientific source. reddit.com
5. 5.Bos JD, Meinardi MM. The 500 Dalton rule for the skin penetration of chemical compounds and drugs. Experimental Dermatology. 2000;9(3):165-169. PubMed
6. 6.National Center for Biotechnology Information. PubChem compound records: glutathione (CID 124886); KPV (CID 125672); GHK-Cu (CID 71587328); NAD+ (CID 5892); BPC-157 (CID 9941957); MOTS-c (CID 146675088); thymosin beta-4 (CID 45382195)
7. 7.UniProt. P62328, Thymosin beta-4 (human). uniprot.org
8. 8.Ho EN, et al. Doping control analysis of TB-500, a synthetic version of an active region of thymosin β4, in equine urine and plasma by liquid chromatography-mass spectrometry. Journal of Chromatography A. 2012;1265:57-69. PubMed
9. 9.Kalia YN, Naik A, Garrison J, Guy RH. Iontophoretic drug delivery. Advanced Drug Delivery Reviews. 2004;56(5):619-658. PubMed
10. 10.Prausnitz MR, Langer R. Transdermal drug delivery. Nature Biotechnology. 2008;26(11):1261-1268. PubMed
11. 11.Williams AC, Barry BW. Penetration enhancers. Advanced Drug Delivery Reviews. 2004;56(5):603-618. PubMed
12. 12.Prausnitz MR. Microneedles for transdermal drug delivery. Advanced Drug Delivery Reviews. 2004;56(5):581-587. PubMed
13. 13.Hasan M, Khatun A, Kogure K. Iontophoresis of biological macromolecular drugs. Pharmaceutics. 2022. PMC
14. 14.Liatsopoulou A, Varvarsou A, Mellou F, Protopapa E. Iontophoresis in dermal delivery: a review of applications in dermato-cosmetic and aesthetic sciences. International Journal of Cosmetic Science. 2023;45. Wiley